O	O	0	1	[	[	O	(	O	17	DEP	O
O	O	1	3	An	An	B-NP	DT	O	3	NMOD	O
O	O	4	18	overexpression	overexpression	I-NP	NN	O	9	SUB	O
O	O	19	21	of	of	B-PP	IN	O	3	NMOD	O
T1	B-Protein	22	30	retinoic	retinoic	B-NP	JJ	B-protein	8	NMOD	B-protein
T1	I-Protein	31	35	acid	acid	I-NP	NN	I-protein	8	NMOD	I-protein
T1	I-Protein	36	44	receptor	receptor	I-NP	NN	I-protein	8	NMOD	I-protein
T1	I-Protein	45	50	alpha	alpha	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	51	57	blocks	block	B-VP	VBZ	O	17	DEP	O
O	O	58	65	myeloid	myeloid	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	66	70	cell	cell	I-NP	NN	I-cell_type	12	NMOD	I-cell_type
O	O	71	86	differentiation	differentiation	I-NP	NN	O	9	OBJ	O
O	O	87	89	at	at	B-PP	IN	O	9	VMOD	O
O	O	90	93	the	the	B-NP	DT	O	16	NMOD	O
O	O	94	106	promyelocyte	promyelocyte	I-NP	JJ	O	16	NMOD	O
O	O	107	112	stage	stage	I-NP	NN	O	13	PMOD	O
O	O	112	113	]	]	O	)	O	0	ROOT	O

O	O	115	123	Retinoic	Retinoic	B-NP	JJ	O	2	NMOD	O
O	O	124	128	acid	acid	I-NP	NN	O	10	NMOD	O
O	O	129	130	(	(	O	(	O	5	DEP	O
O	O	130	132	RA	RA	B-NP	NN	O	5	DEP	O
O	O	132	133	)	)	O	)	O	2	NMOD	O
O	O	133	134	,	,	O	,	O	10	P	O
O	O	135	136	a	a	B-NP	DT	O	10	NMOD	O
O	O	137	144	vitamin	vitamin	I-NP	NN	O	10	NMOD	O
O	O	145	146	A	A	I-NP	NN	O	10	NMOD	O
O	O	147	157	derivative	derivative	I-NP	NN	O	12	SUB	O
O	O	157	158	,	,	O	,	O	10	P	O
O	O	159	165	exerts	exert	B-VP	VBZ	O	0	ROOT	O
O	O	166	167	a	a	B-NP	DT	O	15	NMOD	O
O	O	168	172	wide	wide	I-NP	JJ	O	15	NMOD	O
O	O	173	178	range	range	I-NP	NN	O	12	OBJ	O
O	O	179	181	of	of	B-PP	IN	O	15	NMOD	O
O	O	182	192	biological	biological	B-NP	JJ	O	18	NMOD	O
O	O	193	200	effects	effect	I-NP	NNS	O	16	PMOD	O
O	O	201	208	related	relate	B-VP	VBN	O	18	NMOD	O
O	O	209	211	to	to	B-PP	TO	O	19	AMOD	O
O	O	212	216	cell	cell	B-NP	NN	O	20	PMOD	O
O	O	217	230	proliferation	proliferation	I-NP	NN	O	21	NMOD	O
O	O	231	234	and	and	O	CC	O	21	NMOD	O
O	O	235	250	differentiation	differentiation	B-NP	NN	O	21	NMOD	O
O	O	250	251	.	.	O	.	O	12	P	O

O	O	252	255	The	The	B-NP	DT	O	3	NMOD	O
O	O	256	267	pleiotropic	pleiotropic	I-NP	JJ	O	3	NMOD	O
O	O	268	275	effects	effect	I-NP	NNS	O	6	SUB	O
O	O	276	278	of	of	B-PP	IN	O	3	NMOD	O
O	O	279	281	RA	RA	B-NP	NN	O	4	PMOD	O
O	O	282	285	are	be	B-VP	VBP	O	0	ROOT	O
O	O	286	293	thought	think	I-VP	VBN	O	6	VC	O
O	O	294	296	to	to	I-VP	TO	O	9	VMOD	O
O	O	297	299	be	be	I-VP	VB	O	7	VMOD	O
O	O	300	308	mediated	mediate	I-VP	VBN	O	9	VC	O
O	O	309	316	through	through	B-PP	IN	O	10	VMOD	O
O	O	317	325	specific	specific	B-NP	JJ	O	15	NMOD	O
O	O	326	333	nuclear	nuclear	I-NP	JJ	O	15	NMOD	O
O	O	334	336	RA	RA	I-NP	NN	B-protein	15	NMOD	B-protein
O	O	337	346	receptors	receptor	I-NP	NNS	I-protein	11	PMOD	I-protein
O	O	347	348	(	(	O	(	O	18	DEP	O
O	O	348	352	RARs	RAR	B-NP	NNS	B-protein	18	DEP	B-protein
O	O	352	353	)	)	O	)	O	15	NMOD	O
O	O	353	354	.	.	O	.	O	6	P	O

O	O	355	359	RARs	RAR	B-NP	NNS	B-protein	2	SUB	B-protein
O	O	360	363	are	be	B-VP	VBP	O	0	ROOT	O
O	O	364	371	members	member	B-NP	NNS	O	2	PRD	O
O	O	372	374	of	of	B-PP	IN	O	3	NMOD	O
O	O	375	378	the	the	B-NP	DT	O	11	NMOD	O
O	O	379	386	steroid	steroid	I-NP	NN	O	11	NMOD	O
O	O	386	387	/	/	B-NP	SYM	O	11	NMOD	O
O	O	387	394	thyroid	thyroid	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	395	402	hormone	hormone	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	403	411	receptor	receptor	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	412	423	superfamily	superfamily	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	424	427	and	and	O	CC	O	2	VMOD	O
O	O	428	435	exhibit	exhibit	B-VP	VBP	O	2	VMOD	O
O	O	436	437	a	a	B-NP	DT	O	16	NMOD	O
O	O	438	447	molecular	molecular	I-NP	JJ	O	16	NMOD	O
O	O	448	457	structure	structure	I-NP	NN	O	13	OBJ	O
O	O	458	462	that	that	B-NP	WDT	O	16	NMOD	O
O	O	463	470	possess	possess	B-VP	VBP	O	17	SBAR	O
O	O	471	479	discrete	discrete	B-NP	JJ	O	20	NMOD	O
O	O	480	483	DNA	DNA	I-NP	NN	O	18	OBJ	O
O	O	483	484	-	-	B-NP	HYPH	O	20	NMOD	O
O	O	484	491	binding	bind	B-VP	VBG	O	21	PMOD	O
O	O	492	495	and	and	O	CC	O	30	NMOD	O
T10	B-Entity	496	498	RA	RA	B-NP	NN	B-protein	26	NMOD	B-protein
T10	I-Entity	499	500	(	(	O	(	I-protein	26	NMOD	I-protein
T10	I-Entity	500	506	ligand	ligand	B-NP	NN	I-protein	30	NMOD	I-protein
T10	I-Entity	506	507	)	)	O	)	I-protein	26	NMOD	I-protein
T10	I-Entity	507	508	-	-	O	HYPH	I-protein	30	NMOD	I-protein
T10	I-Entity	508	515	binding	bind	B-NP	VBG	I-protein	30	NMOD	I-protein
T10	I-Entity	516	523	domains	domain	I-NP	NNS	I-protein	22	OBJ	I-protein
O	O	523	524	.	.	O	.	O	2	P	O

O	O	525	527	In	In	B-PP	IN	O	12	VMOD	O
O	O	528	541	hematopoietic	hematopoietic	B-NP	JJ	O	3	NMOD	O
O	O	542	548	system	system	I-NP	NN	O	1	PMOD	O
O	O	548	549	,	,	O	,	O	12	P	O
O	O	550	552	RA	RA	B-NP	NN	O	11	NMOD	O
O	O	553	556	and	and	I-NP	CC	O	11	NMOD	O
O	O	557	561	RARs	RAR	I-NP	NNS	B-protein	11	NMOD	B-protein
O	O	561	562	,	,	O	,	O	11	P	O
O	O	563	576	predominantly	predominantly	B-NP	RB	O	11	NMOD	O
T2	B-Protein	577	580	RAR	RAR	I-NP	NN	B-protein	11	NMOD	B-protein
T2	I-Protein	581	586	alpha	alpha	I-NP	NN	I-protein	12	SUB	I-protein
O	O	587	590	may	may	B-VP	MD	O	0	ROOT	O
O	O	591	595	play	play	I-VP	VB	O	12	VC	O
O	O	596	599	key	key	B-NP	JJ	O	15	NMOD	O
O	O	600	605	roles	role	I-NP	NNS	O	13	OBJ	O
O	O	606	609	for	for	B-PP	IN	O	13	VMOD	O
O	O	610	613	the	the	B-NP	DT	O	20	NMOD	O
O	O	614	627	proliferation	proliferation	I-NP	NN	O	20	NMOD	O
O	O	628	631	and	and	I-NP	CC	O	20	NMOD	O
O	O	632	647	differentiation	differentiation	I-NP	NN	O	16	PMOD	O
O	O	648	650	of	of	B-PP	IN	O	20	NMOD	O
O	O	651	664	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	23	NMOD	B-cell_type
O	O	665	676	progenitors	progenitor	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	676	677	.	.	O	.	O	12	P	O

O	O	678	685	However	However	B-ADVP	RB	O	4	VMOD	O
O	O	685	686	,	,	O	,	O	4	P	O
O	O	687	689	it	it	B-NP	PRP	O	4	SUB	O
O	O	690	692	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	693	702	currently	currently	B-ADVP	RB	O	4	VMOD	O
O	O	703	710	unknown	unknown	B-ADJP	JJ	O	4	PRD	O
O	O	711	714	how	how	B-ADVP	WRB	O	6	AMOD	O
O	O	715	717	RA	RA	B-NP	NN	O	10	NMOD	O
O	O	718	721	and	and	I-NP	CC	O	10	NMOD	O
O	O	722	726	RARs	RAR	I-NP	NNS	B-protein	11	SUB	B-protein
O	O	727	730	are	be	B-VP	VBP	O	7	SBAR	O
O	O	731	739	involved	involve	I-VP	VBN	O	11	VC	O
O	O	740	742	in	in	B-PP	IN	O	12	VMOD	O
O	O	743	753	regulating	regulate	B-VP	VBG	O	13	PMOD	O
O	O	754	760	normal	normal	B-NP	JJ	O	17	NMOD	O
O	O	761	774	hematopoietic	hematopoietic	I-NP	JJ	O	17	NMOD	O
O	O	775	790	differentiation	differentiation	I-NP	NN	O	14	OBJ	O
O	O	790	791	.	.	O	.	O	4	P	O

O	O	792	794	To	To	B-VP	TO	O	2	VMOD	O
O	O	795	799	make	make	I-VP	VB	O	17	VMOD	O
O	O	800	805	clear	clear	B-ADJP	JJ	O	2	VMOD	O
O	O	806	809	the	the	B-NP	DT	O	5	NMOD	O
O	O	810	815	roles	role	I-NP	NNS	O	3	SUB	O
O	O	816	818	of	of	B-PP	IN	O	5	NMOD	O
O	O	819	821	RA	RA	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	822	825	and	and	I-NP	CC	O	10	NMOD	O
T3	B-Protein	826	829	RAR	RAR	I-NP	NN	B-protein	10	NMOD	B-protein
T3	I-Protein	830	835	alpha	alpha	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	836	838	in	in	B-PP	IN	O	5	NMOD	O
O	O	839	842	the	the	B-NP	DT	O	14	NMOD	O
O	O	843	849	normal	normal	I-NP	JJ	O	14	NMOD	O
O	O	850	863	hematopoiesis	hematopoiesis	I-NP	NN	O	11	PMOD	O
O	O	863	864	,	,	O	,	O	17	P	O
O	O	865	866	I	I	B-NP	PRP	O	17	SUB	O
O	O	867	871	have	have	B-VP	VBP	O	0	ROOT	O
O	O	872	882	introduced	introduce	I-VP	VBN	O	17	VC	O
O	O	883	886	the	the	B-NP	DT	O	20	NMOD	O
O	O	887	896	construct	construct	I-NP	NN	O	18	OBJ	O
O	O	897	899	of	of	B-PP	IN	O	20	NMOD	O
O	O	900	905	human	human	B-NP	JJ	B-protein	24	NMOD	B-protein
T4	B-Protein	906	909	RAR	RAR	I-NP	NN	I-protein	24	NMOD	I-protein
T4	I-Protein	910	915	alpha	alpha	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	916	917	(	(	O	(	O	28	DEP	O
T5	B-Protein	917	921	hRAR	hRAR	B-NP	NN	B-protein	27	NMOD	B-protein
T5	I-Protein	922	927	alpha	alpha	I-NP	NN	I-protein	28	DEP	I-protein
O	O	927	928	)	)	O	)	O	24	NMOD	O
O	O	929	933	into	into	B-PP	IN	O	18	VMOD	O
O	O	934	940	murine	murine	B-NP	JJ	B-cell_type	33	NMOD	B-cell_type
O	O	941	945	bone	bone	I-NP	NN	I-cell_type	33	NMOD	I-cell_type
O	O	946	952	marrow	marrow	I-NP	NN	I-cell_type	33	NMOD	I-cell_type
O	O	953	958	cells	cell	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	959	963	with	with	B-PP	IN	O	18	VMOD	O
O	O	964	974	retroviral	retroviral	B-NP	JJ	O	36	NMOD	O
O	O	975	981	vector	vector	I-NP	NN	O	34	PMOD	O
O	O	981	982	,	,	O	,	O	18	P	O
O	O	983	986	and	and	O	CC	O	18	VMOD	O
O	O	987	995	selected	select	B-VP	VBN	O	18	VMOD	O
O	O	996	1004	infected	infected	B-NP	JJ	O	41	NMOD	O
O	O	1005	1010	cells	cell	I-NP	NNS	O	39	OBJ	O
O	O	1011	1015	with	with	B-PP	IN	O	41	NMOD	O
T11	B-Entity	1016	1020	drug	drug	B-NP	NN	B-DNA	45	NMOD	B-DNA
T11	I-Entity	1021	1030	resistant	resistant	I-NP	JJ	I-DNA	45	NMOD	I-DNA
T11	I-Entity	1031	1037	marker	marker	I-NP	NN	I-DNA	42	PMOD	I-DNA
O	O	1038	1039	(	(	O	(	O	51	DEP	O
T12	B-Entity	1039	1042	Neo	Neo	B-NP	NN	B-protein	51	DEP	B-protein
T12	I-Entity	1042	1043	(	(	O	(	O	50	DEP	O
T12	I-Entity	1043	1044	r	r	B-NP	NN	O	50	DEP	O
T12	I-Entity	1044	1045	)	)	O	)	O	47	NMOD	O
O	O	1045	1046	)	)	O	)	O	45	NMOD	O
O	O	1047	1055	cultured	culture	B-VP	VBN	O	45	NMOD	O
O	O	1056	1058	on	on	B-PP	IN	O	52	VMOD	O
O	O	1059	1062	the	the	B-NP	DT	O	57	NMOD	O
O	O	1063	1069	stroma	stroma	I-NP	NN	B-cell_line	57	NMOD	B-cell_line
O	O	1070	1074	cell	cell	I-NP	NN	I-cell_line	57	NMOD	I-cell_line
O	O	1075	1079	line	line	I-NP	NN	I-cell_line	53	PMOD	I-cell_line
O	O	1080	1081	(	(	O	(	O	62	DEP	O
O	O	1081	1084	PA6	PA6	B-NP	NN	B-protein	61	NMOD	B-protein
O	O	1084	1085	-	-	B-NP	HYPH	O	61	P	O
O	O	1085	1088	neo	neo	I-NP	NN	O	62	DEP	O
O	O	1088	1089	)	)	O	)	O	57	NMOD	O
O	O	1089	1090	,	,	O	,	O	17	P	O
O	O	1091	1094	and	and	O	CC	O	17	VMOD	O
O	O	1095	1103	analyzed	analyze	B-VP	VBD	O	17	VMOD	O
O	O	1104	1107	the	the	B-NP	DT	O	67	NMOD	O
O	O	1108	1116	behavior	behavior	I-NP	NN	O	65	OBJ	O
O	O	1117	1119	of	of	B-PP	IN	O	67	NMOD	O
O	O	1120	1128	infected	infected	B-NP	JJ	B-cell_type	70	NMOD	B-cell_type
O	O	1129	1134	cells	cell	I-NP	NNS	I-cell_type	68	PMOD	I-cell_type
O	O	1134	1135	.	.	O	.	O	17	P	O

O	O	1136	1139	All	All	B-NP	DT	O	4	SUB	O
O	O	1140	1142	of	of	B-PP	IN	O	1	NMOD	O
O	O	1143	1152	procedure	procedure	B-NP	NN	O	2	PMOD	O
O	O	1153	1157	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1158	1162	done	do	I-VP	VBN	O	4	VC	O
O	O	1163	1165	in	in	B-ADVP	FW	O	5	VMOD	O
O	O	1166	1171	vitro	vitro	I-ADVP	FW	O	6	AMOD	O
O	O	1171	1172	.	.	O	.	O	4	P	O

O	O	1173	1177	Most	Most	B-NP	JJS	O	2	NMOD	O
O	O	1178	1183	cells	cell	I-NP	NNS	O	7	SUB	O
O	O	1184	1192	infected	infect	B-VP	VBN	O	2	NMOD	O
O	O	1193	1197	with	with	B-PP	IN	O	3	VMOD	O
T6	B-Protein	1198	1202	hRAR	hRAR	B-NP	NN	B-protein	6	NMOD	B-protein
T6	I-Protein	1203	1208	alpha	alpha	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	1209	1218	exhibited	exhibit	B-VP	VBD	O	0	ROOT	O
O	O	1219	1232	promyelocytic	promyelocytic	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	1233	1243	morphology	morphology	I-NP	NN	I-cell_type	7	OBJ	I-cell_type
O	O	1244	1247	and	and	O	CC	O	7	VMOD	O
O	O	1248	1252	were	be	B-VP	VBD	O	7	VMOD	O
O	O	1253	1260	thought	think	I-VP	VBN	O	11	VC	O
O	O	1261	1263	to	to	I-VP	TO	O	14	VMOD	O
O	O	1264	1266	be	be	I-VP	VB	O	12	VMOD	O
O	O	1267	1274	blocked	block	I-VP	VBN	O	14	VC	O
O	O	1275	1277	at	at	B-PP	IN	O	15	VMOD	O
O	O	1278	1281	the	the	B-NP	DT	O	19	NMOD	O
O	O	1282	1295	promyelocytic	promyelocytic	I-NP	JJ	O	19	NMOD	O
O	O	1296	1301	stage	stage	I-NP	NN	O	16	PMOD	O
O	O	1302	1304	in	in	B-PP	IN	O	19	NMOD	O
O	O	1305	1310	their	their	B-NP	PRP$	O	23	NMOD	O
O	O	1311	1318	myeloid	myeloid	I-NP	JJ	O	23	NMOD	O
O	O	1319	1334	differentiation	differentiation	I-NP	NN	O	20	PMOD	O
O	O	1334	1335	.	.	O	.	O	7	P	O

O	O	1336	1347	Furthermore	Furthermore	B-ADVP	RB	O	6	VMOD	O
O	O	1347	1348	,	,	O	,	O	6	P	O
O	O	1349	1354	these	these	B-NP	DT	O	5	NMOD	O
O	O	1355	1363	immature	immature	I-NP	JJ	B-cell_type	5	NMOD	B-cell_type
O	O	1364	1369	cells	cell	I-NP	NNS	I-cell_type	6	SUB	I-cell_type
O	O	1370	1384	differentiated	differentiate	B-VP	VBD	O	0	ROOT	O
O	O	1385	1395	terminally	terminally	B-ADVP	RB	O	6	VMOD	O
O	O	1396	1400	into	into	B-PP	IN	O	6	VMOD	O
O	O	1401	1407	mature	mature	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	1408	1420	granulocytes	granulocyte	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	1421	1423	by	by	B-PP	IN	O	6	VMOD	O
O	O	1424	1430	adding	add	B-VP	VBG	O	11	PMOD	O
O	O	1431	1435	with	with	B-PP	IN	O	12	VMOD	O
O	O	1436	1438	RA	RA	B-NP	NN	O	13	PMOD	O
O	O	1439	1440	(	(	O	(	O	20	DEP	O
O	O	1440	1442	10	10	B-NP	CD	O	20	DEP	O
O	O	1442	1443	(	(	O	(	O	20	DEP	O
O	O	1443	1444	-	-	O	SYM	O	20	DEP	O
O	O	1444	1445	6	6	O	CD	O	18	PRD	O
O	O	1445	1446	)	)	O	)	O	14	NMOD	O
O	O	1447	1448	M	M	B-NP	NN	O	13	PMOD	O
O	O	1448	1449	)	)	O	)	O	6	VMOD	O
O	O	1449	1450	.	.	O	.	O	6	P	O

T7	B-Protein	1451	1454	RAR	RAR	B-NP	NN	B-protein	2	NMOD	B-protein
T7	I-Protein	1455	1460	alpha	alpha	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	1461	1469	infected	infected	I-NP	JJ	O	4	NMOD	O
O	O	1470	1475	cells	cell	I-NP	NNS	O	5	SUB	O
O	O	1476	1480	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1481	1485	also	also	B-ADVP	RB	O	5	VMOD	O
O	O	1486	1490	able	able	B-ADJP	JJ	O	5	PRD	O
O	O	1491	1493	to	to	B-VP	TO	O	9	VMOD	O
O	O	1494	1507	differentiate	differentiate	I-VP	VB	O	7	AMOD	O
O	O	1508	1512	into	into	B-PP	IN	O	9	VMOD	O
O	O	1513	1519	mature	mature	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	1520	1531	macrophages	macrophage	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	1532	1534	in	in	B-PP	IN	O	9	VMOD	O
O	O	1535	1538	the	the	B-NP	DT	O	15	NMOD	O
O	O	1539	1543	both	both	I-NP	NN	O	13	PMOD	O
O	O	1544	1546	of	of	B-PP	IN	O	15	NMOD	O
O	O	1547	1551	long	long	B-NP	JJ	O	19	NMOD	O
O	O	1552	1556	term	term	I-NP	NN	O	19	NMOD	O
O	O	1557	1564	culture	culture	I-NP	NN	O	22	NMOD	O
O	O	1565	1568	and	and	O	CC	O	22	NMOD	O
O	O	1569	1572	IL3	IL3	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	1573	1579	colony	colony	I-NP	NN	O	16	PMOD	O
O	O	1579	1580	.	.	O	.	O	5	P	O

O	O	1581	1586	These	These	B-NP	DT	O	2	NMOD	O
O	O	1587	1599	observations	observation	I-NP	NNS	O	3	SUB	O
O	O	1600	1607	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1608	1612	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1613	1615	an	an	B-NP	DT	O	6	NMOD	O
O	O	1616	1630	overexpression	overexpression	I-NP	NN	O	11	SUB	O
O	O	1631	1633	of	of	B-PP	IN	O	6	NMOD	O
T8	B-Protein	1634	1637	RAR	RAR	B-NP	NN	B-protein	9	NMOD	B-protein
T8	I-Protein	1638	1643	alpha	alpha	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	1644	1649	alone	alone	B-ADVP	RB	O	9	NMOD	O
O	O	1650	1652	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	1653	1662	effective	effective	B-ADJP	JJ	O	11	PRD	O
O	O	1663	1665	to	to	B-VP	TO	O	14	VMOD	O
O	O	1666	1674	suppress	suppress	I-VP	VB	O	12	AMOD	O
O	O	1675	1682	myeloid	myeloid	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	1683	1687	cell	cell	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	1688	1703	differentiation	differentiation	I-NP	NN	O	14	OBJ	O
O	O	1704	1707	and	and	O	CC	O	4	DEP	O
T9	B-Protein	1708	1711	RAR	RAR	B-NP	NN	B-protein	20	NMOD	B-protein
T9	I-Protein	1712	1717	alpha	alpha	I-NP	NN	I-protein	21	SUB	I-protein
O	O	1718	1723	plays	play	B-VP	VBZ	O	4	DEP	O
O	O	1724	1725	a	a	B-NP	DT	O	24	NMOD	O
O	O	1726	1733	crucial	crucial	I-NP	JJ	O	24	NMOD	O
O	O	1734	1738	role	role	I-NP	NN	O	21	OBJ	O
O	O	1739	1741	in	in	B-PP	IN	O	21	VMOD	O
O	O	1742	1745	the	the	B-NP	DT	O	28	NMOD	O
O	O	1746	1754	terminal	terminal	I-NP	JJ	O	28	NMOD	O
O	O	1755	1770	differentiation	differentiation	I-NP	NN	O	25	PMOD	O
O	O	1771	1773	of	of	B-PP	IN	O	28	NMOD	O
O	O	1774	1781	myeloid	myeloid	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	1782	1792	precursors	precursor	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	1792	1793	.	.	O	.	O	3	P	O

O	O	1794	1797	The	The	B-NP	DT	O	2	NMOD	O
O	O	1798	1804	system	system	I-NP	NN	O	5	SUB	O
O	O	1805	1814	described	describe	B-VP	VBN	O	2	NMOD	O
O	O	1815	1819	here	here	B-ADVP	RB	O	3	VMOD	O
O	O	1820	1823	may	may	B-VP	MD	O	0	ROOT	O
O	O	1824	1829	serve	serve	I-VP	VB	O	5	VC	O
O	O	1830	1832	as	as	B-PP	IN	O	6	VMOD	O
O	O	1833	1834	a	a	B-NP	DT	O	9	NMOD	O
O	O	1835	1840	model	model	I-NP	NN	O	7	PMOD	O
O	O	1841	1844	for	for	B-PP	IN	O	9	NMOD	O
O	O	1845	1853	studying	study	B-VP	VBG	O	10	PMOD	O
O	O	1854	1857	the	the	B-NP	DT	O	15	NMOD	O
O	O	1858	1861	the	the	I-NP	DT	O	15	NMOD	O
T13	B-Entity	1862	1871	essential	essential	I-NP	JJ	B-DNA	15	NMOD	B-DNA
T13	I-Entity	1872	1877	genes	gene	I-NP	NNS	I-DNA	11	OBJ	I-DNA
O	O	1878	1881	for	for	B-PP	IN	O	15	NMOD	O
O	O	1882	1897	differentiation	differentiation	B-NP	NN	O	16	PMOD	O
O	O	1898	1900	of	of	B-PP	IN	O	17	NMOD	O
O	O	1901	1907	normal	normal	B-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	1908	1912	bone	bone	I-NP	NN	I-cell_type	22	NMOD	I-cell_type
O	O	1913	1919	marrow	marrow	I-NP	NN	I-cell_type	22	NMOD	I-cell_type
O	O	1920	1925	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	1925	1926	.	.	O	.	O	5	P	O
